Artesunate, the recommended drug for severe malaria, rapidly clears the malaria parasite
from infected patients but frequently induces anemia—called post-artesunate delayed …

Episodes of delayed hemolysis 2–6 weeks after treatment of severe malaria with
intravenous artesunate have been described. We performed a prospective observational …

In the last decade it has become clear that, similarly to nucleated cells, enucleated red blood
cells (RBCs) are susceptible to programmed apoptotic cell death. Erythrocytic apoptosis …

Background Artemisinin-based combination treatments (ACTs) are the first-line treatments of
uncomplicated Plasmodium falciparum malaria in many endemic areas but there are few …

Background Late-appearing anaemia (LAA) following treatment with artemisinins for severe
malaria has been reported and well described, but there are limited clinical and …

In stable transmission areas, malaria is the leading cause of anemia in children. Anemia in
children is proposed as an added sensitive indicator for community changes in malaria …

Background Artemisinin-based combination therapies are recommended as first-line
treatments for uncomplicated falciparum malaria, but there is little evaluation of their efficacy …

Background Early rising asexual parasitaemia (ERAP), initially defined as 'an increase in the
parasite count over the baseline pre-treatment level during the first 24 h of treatment'of …

Anaemia following Artemisinin-Based Combination Treatments of Uncomplicated Plasmodium
falciparum Malaria in Children: Temporal Patterns of Haematocrit and the Use of …

Background: There are few publications on anemia following artesunate treatment.
Objective: To investigate the hemoglobin in patients with severe Plasmodium falciparum …